Product Description
- Active Ingredient: Palbociclib (125 mg)
- Mechanism of Action: Palbociclib works by blocking the proteins CDK4 and CDK6, which are essential for cell growth and division. This action stops the cancer cell cycle, preventing the uncontrolled multiplication and spread of cancer cells. It is a targeted therapy, not a traditional chemotherapy.
- Uses: It is specifically indicated for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer that has spread to other parts of the body. It is always used in combination with other hormonal anticancer therapies, such as an aromatase inhibitor or fulvestrant.
- Dosage/Administration: The typical dosage involves taking one 125 mg capsule orally once daily for 21 consecutive days, followed by a 7-day break, completing a 28-day cycle. The capsules must be swallowed whole with food at the same time each day and should not be opened, crushed, or chewed.
How PICLIB 125MG TABS WorkPICLIB 125MG Tablets contain Palbociclib, an antineoplastic agent that works by inhibiting CDK4 and CDK6 proteins, slowing the growth of cancer cells in patients with advanced or metastatic breast cancer. This action specifically targets hormone receptor-positive, HER2-negative types, supporting more effective and targeted treatment outcomes.
Usage and Dosage GuidelinesPICLIB 125MG is suitable for adults and must be taken as instructed by your healthcare provider. Tablets are intended for oral use and should be consumed with food, at approximately the same time each day. Never alter your prescribed dosage or schedule without consulting your oncology team.
Storage and Packaging InformationPICLIB 125MG Tablets are packed in Alu-Alu blister strips, with each box containing 30 tablets. Store the tablets below 30C and keep them safe from moisture. Always keep the medication out of reach of children and do not use after the expiry date indicated on the packaging.
FAQ's of PICLIB 125MG TABS:
Q: How should PICLIB 125MG Tablets be taken for best results?
A: PICLIB 125MG should be taken orally with food, at the same time each day, following your physician's specific dosing schedule. Do not adjust the dosage without medical advice.
Q: What is the recommended use of PICLIB 125MG TABS?
A: This medicine is recommended for adults diagnosed with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer, and should be used only under a doctor's prescription.
Q: When should the tablets be avoided?
A: PICLIB 125MG is not recommended during pregnancy or lactation, and should not be taken by children or those with known hypersensitivity to Palbociclib.
Q: Where should PICLIB 125MG Tablets be stored?
A: Tablets should be kept below 30C, protected from moisture, and stored in their original blister packaging until use.
Q: What are common side effects associated with PICLIB 125MG?
A: Patients may experience neutropenia, increased risk of infections, fatigue, and nausea. Consult your doctor promptly if any side effects become severe or persistent.
Q: What is the benefit of using PICLIB 125MG in breast cancer treatment?
A: PICLIB 125MG Tablets help slow cancer cell growth in specific breast cancer subtypes, contributing to improved progression-free survival rates for eligible patients.